DRDO developed 2 DG anti-COVID drug will reduce the recovery time & oxygen dependency in patients

New Delhi: The first batch of the adjunct COVID therapy anti-COVID drug, 2-deoxy-D-glucose (2-DG), was released by Defense minister Rajnath Singh and...

By Newsmeter Network  Published on 17 May 2021 10:15 AM GMT